Breaks Categories: News

WednesdayJan 31, 2024 11:51 am

NetworkNewsBreaks — DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Announces Plans to Release Financial Report, Schedules Earnings Call

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will release its Q4 2023 and FY 2023 financial results next month. The company plans to release the report market close on Feb. 13, 2024; the company will host a conference call and webcast at 5 p.m. ET the same day. Both the call and webcast are open to the general public. During the event, members of the DDI management team will review the financial report, provide a business update, and answer questions during a Q&A session. A replay of the call and…

Continue Reading

WednesdayJan 31, 2024 10:28 am

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Announces ‘Staggering’ Projected Numbers in Colored Gemstone, Gold Markets in India

GEMXX (OTC: GEMZ), a leading provider of exquisite gemstone jewelry, is reporting on the forecasted growth for the next decade in India’s “burgeoning” jewelry market, which should position the country as a key player in the global jewelry industry. The company noted that, according to recent industry forecasts, the jewelry market in India is poised for exceptional expansion, with some forecasts noting an estimated increase of $21.54 billion in the next four years alone as the sector sees a compound annual growth rate (“CAGR”) of 5.54% in the next four years and 10.5% CAGR between 2023 and 2033. According to…

Continue Reading

TuesdayJan 30, 2024 2:03 pm

NetworkNewsBreaks — Nextech3D.ai (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS) Inks 3D Modeling Deal with Industrial, Commercial Equipment ‘Titan’

Nextech3D.ai (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS), a generative artificial-intelligence  (“AI”)-powered 3D model supplier for Amazon, P&G, Kohls and other major e-commerce retailers, has signed a new 3D modeling contract with Global Industrial Company, a titan in the industrial and commercial equipment sector with more than seven decades of market leadership. According to the announcement, the contract “has significant growth potential, as Global Industrial is an industry leader with 1.7-plus million products in 21 industrial and commercial categories including building supplies, storage and shelving, workbenches and shop desks, and more.” The new contract with Global Industrial reflects Nextech3D.ai's growing presence in…

Continue Reading

TuesdayJan 30, 2024 1:57 pm

NetworkNewsBreaks — ARX Capital Markets Issues Update on New Rules That Mark Pivotal Moment for SPACs

ARX has issued an important update regarding new regulations implemented by the Securities and Exchange Commission (“SEC”) effective Jan. 24, 2024. The regulations are concerning Special Purpose Acquisition Companies (“SPACs”) and de-SPAC transactions, with the rules signifying a major shift in the regulatory framework, enhancing transparency and investor protection in SPAC activities. “The implementation of the SEC’s new regulations on SPACs coincides with a downturn in market activity, heralding a shift towards increased oversight. This change aims to bolster market stability through enhanced transparency and investor protection. Consequently, SPACs are likely to adopt more cautious financial projections, and the market…

Continue Reading

TuesdayJan 30, 2024 1:53 pm

NetworkNewsBreaks — Astiva Health Featured in Bell2Bell Podcast

Astiva Health, which is rapidly making its mark in the Medicare Advantage Prescription Drug (“MAPD”) sector with its commitment to transforming personalized and comprehensive healthcare, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Tri T. Nguyen, the co-founder and CEO of Astiva Health, joined the program to offer insights into the company’s foundations and its unique business model. “Astiva was established in 2020, with our operations commencing on Jan. 1, 2021, in Orange County and San Diego. Recently, we’ve expanded our services…

Continue Reading

TuesdayJan 30, 2024 1:47 pm

NetworkNewsBreaks — Jeffs’ Brands Ltd. (NASDAQ: JFBR, JFBRW) Closes on $7.275M Private Placement

Jeffs’ Brands Ltd (NASDAQ: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, has closed on its recently announced private placement. The placement, which closed on Jan. 29, 2024, was with specific institutional investors. According to the announcement, gross cash proceeds from the placement totaled $7.275 million before deductions and expenses. Jeffs’ Brands anticipates using the net proceeds for working capital and general corporate purposes; funds could also be used for acquisitions, although the company has no pending acquisitions at this time. The company observes that, in connection with the private placement, it issued 2,704,461 units and prefunded…

Continue Reading

TuesdayJan 30, 2024 1:43 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Expands Sales Dominican Republic, Caribbean Markets with Grupo Cavel Order

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a vehicle order from Grupo Cavel for the sale of EVs its Electric Motors dealerships located in the Dominican Republic and Caribbean. The order was for 20 CAMPUS EV cargo vans. According to the announcement, Grupo Cavel plans to order additional vehicles and will be establishing a sales and service distribution channel for Mullen’s lineup of commercial EVs in the two countries. Grupo Cavel is a key retail automotive group in the Dominican Republic and has existing relationships in vehicle sales, distribution, warranty and servicing throughout the Caribbean.…

Continue Reading

TuesdayJan 30, 2024 1:31 pm

NetworkNewsBreaks – IBN, BioMedWire to Serve as Official Media Partners for BioPharma Nexus Events

IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, has announced its media collaboration with BioPharma Nexus for upcoming events in 2024. BioMedWire, a specialized communications platform dedicated to the life sciences sector and a vital component of IBN’s Dynamic Brand Portfolio, will also serve as an official media partner for the events. Renowned for its expertise in life sciences, BioPharma Nexus organizes industry leading events covering clinical trials, drug discovery, medical affairs, pharmaceutical supply chains and related logistics. The events are tailored to optimize productivity and enhance global networking opportunities. “Rapid advancements in medical solutions, novel business structures, digital…

Continue Reading

TuesdayJan 30, 2024 1:23 pm

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) to Implement 1-for-40 Reverse Split

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, has announced a 1-for-40 reverse split of its common stock. The reverse split will go into effect tomorrow, Jan. 31, 2024. According to the company, its common stock will trade on a post-split basis at the beginning of the trading day on Jan. 31, under its existing trading symbol: SIGY. The announcement included pertinent stockholder information regarding the upcoming split. “The reverse stock split is intended to increase the market price per share of the company’s common stock to gain compliance with the minimum bid listing requirement of the NASDAQ Capital…

Continue Reading

TuesdayJan 30, 2024 12:52 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Submission of IND for Planned Phase 1b Hypertension Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension clinical trial of DehydraTECH-CBD. According to the announcement, the company had a successful pre-IND meeting with FDA officials. Following the guidance provided in that meeting regarding the development and filing of the IND, the company submitted the application on Jan. 29, 2024. The company will now wait 30 calendar days before initiating any clinical trials, in compliance with FDA guidelines.…

Continue Reading